Should you perform total body skin exams on patients to screen for skin cancer in patients using topical ruxolitinib?

Featuring Tina Bhutani-Jacques, MD, MAS |

CEO, Synergy Dermatology  
Associate Clinical Professor of Dermatology  
University of California, SF  
San Francisco, CA

| Published February 15, 2023

Loading...

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved